AT
This startup provides a machine learning platform that generates synthetic external data for clinical trials, particularly for rare diseases. Their statistically rigorous approach allows organizations to conduct data-driven adaptive trials, accelerating the development of treatments for underserved patient populations.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- This startup provides a machine learning platform that generates synthetic external data for clinical trials, particularly for rare diseases. Their statistically rigorous approach allows organizations to conduct data-driven adaptive trials, accelerating the development of treatments for underserved patient populations.